In a remarkable milestone for India’s medical device industry, a next-generation heart stent developed in India has received major global recognition, highlighting the country’s growing innovation and self-reliance in advanced cardiovascular technologies.

The indigenous stent, designed and manufactured under the ‘Make in India’ initiative, has been lauded for its cutting-edge design, superior safety profile, and clinical efficacy—putting it on par with leading international brands. The recognition came from a leading global regulatory and research consortium, which evaluated the product for biocompatibility, restenosis prevention, and long-term patient outcomes.

Engineered with advanced alloy composition and next-gen polymer coating, the stent offers enhanced flexibility, faster healing, and minimal arterial inflammation—making it a promising solution for millions of cardiac patients in India and abroad.

This achievement underscores India’s emergence as a global medtech innovation hub, capable of developing complex, high-performance medical devices that meet stringent international standards.

Industry experts hailed this recognition as a breakthrough moment for India’s cardiovascular device ecosystem, noting that it opens doors for greater export potential, foreign collaborations, and trust in indigenous R&D capabilities.

A senior official from the Ministry of Health and Family Welfare said, “This recognition validates the world-class innovation happening in India’s medtech sector and reflects our commitment to making advanced, affordable, and accessible medical devices for all.”

The development not only strengthens India’s position in the global medical device market but also reinforces its mission of ‘Atmanirbhar Bharat’ in healthcare innovation